Abstract
This article examines prostate cancer as a target for immunotherapy and investigates active immunotherapy for prostate cancer, combining conventional therapy with active immunotherapy, immune modulators (brakes and accelerators), and monoclonal antibodies.
Original language | English (US) |
---|---|
Pages (from-to) | 121-129 |
Number of pages | 9 |
Journal | Urologic Clinics of North America |
Volume | 37 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2010 |
Keywords
- CTLA4
- Lymphocyte
- PD-1
- Prostate cancer
- T cell
- Vaccine
ASJC Scopus subject areas
- Urology